[A Real-world Study on the Expression Characteristics of PD-L1 in Patients  with Advanced EGFR Positive NSCLC and Its Relationship with the  Therapeutic Efficacy of EGFR-TKIs]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.